Quality of Life Among Diabetic and Non-diabetic Patients on Maintenance Haemodialysis

Abstract

Aims: To compare the quality of life of end stage renal disease (ESRD) diabetic and non-diabetic patients undergoing chronic haemodialysis.

Methods: A case-control study of 54 diabetic and 60 non-diabetic patients undergoing maintenance haemodialysis. All subjects completed the Kidney Disease Quality of Life Short Form (KDQOL-SF) version 1.3 questionnaire as well as the SF-36 Health Survey (SF-36).

Results: When compared to the control non-diabetic group, physical health was significantly impaired in diabetic dialysis patients (P<0.005) and staff encouragement was significantly worse (P<0.05). In both groups, all other compounds of the SF-46 and variables related to kidney disease were similar.

Conclusions: To improve diabetic haemodialysis patients’ quality of life, physical activity should be incorporated to the routine dialysis care and health care professionals should support them more intensively.

diabetes - dialysis - quality of life

References

• 1 Zimmet P, Albereti KG, Shaw J. Global and societal implications of the diabetes epidemic.  Nature. 2001;  414 782-787
• 2 Valensi P. et al . Pre-diabetes essential action: a European perspective.  Diabetes Metab. 2005;  31 ((6)) 606-620
• 3 Martin S, Schramm W, Schneider B. et al . Epidemiology of Complications and Total Treatment Costs from Diagnosis of Type 2 Diabetes in Germany (ROSSO4).  Exp Clin Endocrinol Diabetes. 2007;  115 495-501
• 4 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections.  Diabetes Care. 1998;  21 ((9)) 1414-1431
• 5 Schwarz PEH, Lindstrom J, Kissimova-Scarbeck K. et al . The European Perspective of type 2 Diabetes Prevention: Diabetes in Europe – Prevention Using Lifestyle, Physical Activity and Nuritional Intervention (DE-PLAN) Project.  Exp Clin Endocrinol Diabetes. 2008;  116 167-172
• 6 Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice Nephropathy in patients with type 2 diabetes.  N Engl J Med. 2002;  15 1145-1151
• 7 Keane WF, Brenner BM, Zeeuw D de. et al . The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study.  Kidney Int. 2003;  63 1499-1507
• 8 Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice.  Semin Dial. 2005;  18 82-90
• 9 Leggat JE. Adherence with dialysis: A focus on mortality risk.  Semin Dial. 2005;  18 137-141
• 10 Hays RD, Kallich JD, Mapes DL. et al . Development of the Kidney Disease Quality of Life (KDQOL) instrument.  Qoal Life Res. 1994;  3 329-338
• 11 Kutner NG. Assessing end – stage renal disease patients’ functioning and well-being: measurement approches and implications for clinical practice.  Am J Kidney Dis. 1994;  24 321-333
• 12 National Kidney Foundation: KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations . 2006 updates: haemodialysis adequacy, peritoneal dialysis adequacy and vascular access.  Am J Kidney Dis. 2006;  48 ((Suppl 1)) S1-S322
• 13 Kimmel PL. Just whose quality of life is it anyway? Controversies and consistencies in measurement of quality of life.  Kidney Int. 2000;  57 S113-S120
• 14 Korevaar JC, Markus MP, Jansen MA. et al For the Netherlands Cooperative Study on the Adequacy of Dialysis (NESCOSAD) Study Group . Validation of KDQOL-SF: a dialysis-targeted health measure.  Qual Life Res. 2002;  11 437-447
• 15 Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual (4th printing, revised). Boston, MA. Health Institute 1994
• 16 Sorensen VR, Mathiesen T, Watt JB. et al . Diabetic patients treated with dialysis: complications and quality of life.  Diabetologia. 2007;  50 2254-2262
• 17 MacHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form Heath survey (SF-36): II. Psychometric and clinical tests of validity on measuring and mental health constructs.  Med Care. 1993;  31 247-263
• 18 Merkus MP, Jager KJ, Dekker FW. et al . Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis.
• 19 Philips L, Simon J. et al . Health related quality of life assessment in end-stage renal failure.  Nursing Times Research. 2001;  6 658-670
• 20 Hollej Jl, Nespor S. An analysis of factors affecting employment of chronic dialysis patients.  Am J Kidney Dis. 1994;  23 681-685
• 21 Painter P, Carlson L, Carey S. et al . Low functioning haemodialysis patients improve with exercise training.  Am J Kidney Dis. 2000;  36 600-608
• 22 Molsted S, Eidemak I, Sorensen HT. et al . Five months of physical exercise in haemodialysis patients: effects of aerobic capacity, physical function and self-rated health.  Nephron Clin Pract. 2004;  96 c76-c81
• 23 National Kidney Foundation . K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.  Am J Kidney Dis. 2005;  45 ((Suppl 3)) S1-S154
• 24 Painter P, Johansen KL. Improving physical functioning. Time to be a part of routine care.  Am J Kidney Dis. 2006;  48 167-170
• 25 Cheema BS, Smith BC, Fiatarone Singh MA. A rationale for intradialytic exercise training as standard clinical practice in ESRD.  Am J Kidney Dis. 2005;  45 912-916
• 26 Lopes AA, Albert JM, Young EW. et al . Screening for depression in hemodialysis patients: Association with diagnosis, treatment, and outcomes in the DOPPS.  Kidney Int. 2004;  66 2047-2053
• 27 Watnick S, Kirwin P, Mahnensmith R. et al . The prevalence and treatment of depression among patients starting dialysis.  Am J Kidney Dis. 2003;  41 105-110
• 28 Mozes B, Shabtai E, Zucker D. Differences in quality of life among patients receiving dialysis replacement therapy at seven medical centers.  J Clin Epidemiol. 1997;  50 1035-1043
• 29 Held PJ, Port FK, Wolfe RA. et al . The dose of hemodialysis and patient mortality.  Kidney Int. 1996;  50 550-556
• 30 Evans RW, Rader B, Manninen DL. the cooperative Multicenter EPO Clinical Trial Group . The quality of life of hemodialysis recipients treated with recombinant human erytropoetin.  J Am Med Assoc. 1190;  263 825-830

Correspondence